{"filing":{"accession_number":"0001193125-26-365271","cik":"0001958086","ticker":"CLB","company_name":"Core Laboratories Inc. /DE/","form":"8-K","filing_date":"2026-08-25","report_date":"2026-08-19","primary_document":"clb-20260819.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1958086/000119312526365271/clb-20260819.htm"},"events":[{"id":29538,"run_id":27049,"accession_number":"0001193125-26-365271","anchor_item_number":"5.02","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"Kwaku Temeng, a director and Chairman of the Nominating Committee, resigned effective October 1, 2026, due to disagreement with the Board regarding strategic direction and governance practices, specifically succession planning and research priorities. This is a clear director departure triggered by substantive governance disagreement, material to investors assessing board stability and strategic alignment.","company_name":"Core Laboratories Inc. /DE/","ticker":"CLB","filing_date":"2026-08-25","form":"8-K","submitted_at":null,"items":[{"id":31854,"accession_number":"0001193125-26-365271","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Kwaku Temeng, a director and Chairman of the Nominating Committee, resigned effective October 1, 2026, due to disagreement with the Board regarding strategic direction and governance practices, specifically succession planning and research priorities. This is a clear director departure triggered by substantive governance disagreement, material to investors assessing board stability and strategic alignment.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-25T20:52:36.701457+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":31854,"accession_number":"0001193125-26-365271","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Kwaku Temeng, a director and Chairman of the Nominating Committee, resigned effective October 1, 2026, due to disagreement with the Board regarding strategic direction and governance practices, specifically succession planning and research priorities. This is a clear director departure triggered by substantive governance disagreement, material to investors assessing board stability and strategic alignment.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-25T20:52:36.701457+00:00","company_name":"Core Laboratories Inc. /DE/","ticker":"CLB","filing_date":"2026-08-25"}]}